NL7605841A - Isoxazoolderivaten, hun bereiding en geneesmid- delen met deze verbindingen. - Google Patents

Isoxazoolderivaten, hun bereiding en geneesmid- delen met deze verbindingen.

Info

Publication number
NL7605841A
NL7605841A NL7605841A NL7605841A NL7605841A NL 7605841 A NL7605841 A NL 7605841A NL 7605841 A NL7605841 A NL 7605841A NL 7605841 A NL7605841 A NL 7605841A NL 7605841 A NL7605841 A NL 7605841A
Authority
NL
Netherlands
Prior art keywords
compounds
preparation
products containing
medicinal products
isoxazole derivatives
Prior art date
Application number
NL7605841A
Other languages
English (en)
Other versions
NL178596C (nl
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2524959A external-priority patent/DE2524959C2/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NL7605841A publication Critical patent/NL7605841A/nl
Application granted granted Critical
Publication of NL178596C publication Critical patent/NL178596C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NLAANVRAGE7605841,A 1975-06-05 1976-05-31 Werkwijze voor het bereiden van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor het bereiden van daarin als geneeskrachtige verbindingen te gebruiken 5-methylisoxazool-4-carbonzuuraniliden. NL178596C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2524959A DE2524959C2 (de) 1975-06-05 1975-06-05 5-Methyl-isoxazol-4-carbonsäureanilide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Mittel

Publications (2)

Publication Number Publication Date
NL7605841A true NL7605841A (nl) 1976-12-07
NL178596C NL178596C (nl) 1986-04-16

Family

ID=5948292

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7605841,A NL178596C (nl) 1975-06-05 1976-05-31 Werkwijze voor het bereiden van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor het bereiden van daarin als geneeskrachtige verbindingen te gebruiken 5-methylisoxazool-4-carbonzuuraniliden.

Country Status (15)

Country Link
US (1) US4087535A (nl)
JP (1) JPS5938230B2 (nl)
AT (1) AT349007B (nl)
BE (1) BE842689A (nl)
CA (1) CA1076584A (nl)
CH (1) CH603608A5 (nl)
DK (1) DK151013C (nl)
ES (1) ES448386A1 (nl)
FR (1) FR2313052A1 (nl)
GB (1) GB1547452A (nl)
IE (1) IE43136B1 (nl)
IT (1) IT1063592B (nl)
LU (1) LU75077A1 (nl)
MX (1) MX3144E (nl)
NL (1) NL178596C (nl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991017748A1 (de) * 1990-05-18 1991-11-28 Hoechst Aktiengesellschaft Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2654797A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Verfahren zur herstellung von isoxazolderivaten
JPS54102196U (nl) * 1977-12-28 1979-07-18
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
FI71129C (fi) * 1979-06-11 1986-11-24 Ciba Geigy Ag Foerfarande foer framstaellning av farmaceutiskt aktiva alfakarbamoylpyrrolpropionitriler
DE2940189A1 (de) * 1979-10-04 1981-04-16 Basf Ag, 6700 Ludwigshafen Isoxazolylcarbonsaeureanilide, verfahren zu ihrer herstellung und ihre verwendung als fungizide
FR2538806B1 (fr) * 1982-12-30 1986-02-21 Bago Sa Labor Composes phenyl-3 methyl isoxazole-5 carboxy-4 anilides substitues, actifs therapeutiquement contre l'inflammation et la douleur
JPS6398092A (ja) * 1986-10-14 1988-04-28 富士電機株式会社 金券用カ−ド残金精算装置
US4935434A (en) * 1988-01-26 1990-06-19 Bristol-Myers Company Antiarthritic isoxazole-4-carboxamides
US5583150A (en) * 1989-08-18 1996-12-10 Alcon Laboratories, Inc. 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
DD297328A5 (de) 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
US5108999A (en) * 1990-02-02 1992-04-28 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
US6133301A (en) * 1991-08-22 2000-10-17 Aventis Pharma Deutschland Gmbh Pharmaceuticals for the treatment of rejection reactions in organ transplantations
DE4127737A1 (de) * 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
GB9320299D0 (en) * 1993-10-01 1993-11-17 Roussel Lab Ltd Isoxazole derivatives
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US5624946A (en) * 1994-07-05 1997-04-29 Williams; James Use of leflunomide to control and reverse chronic allograft rejection
US5721277A (en) * 1995-04-21 1998-02-24 Sugen, Inc. Compounds and methods for inhibiting hyper-proliferative cell growth
US6331555B1 (en) 1995-06-01 2001-12-18 University Of California Treatment of platelet derived growth factor related disorders such as cancers
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
EP0903345B1 (de) * 1997-08-08 2000-10-04 Aventis Pharma Deutschland GmbH Kristallform von 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid
US7691890B2 (en) 1998-03-11 2010-04-06 James W. Williams Anti-viral uses of leflunomide products
US20050255071A1 (en) * 1998-12-10 2005-11-17 Aventis Pharma Deutschland Gmbh Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors
AR033459A1 (es) 2001-04-05 2003-12-17 Aventis Pharma Inc Uso de (41-trifluorometilfenil)-amida del acido (z)-2-ciano-3-hidroxi-but-2-enoico para el tratamiento de la esclerosis multiple
GB0123571D0 (en) * 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
US20050158371A1 (en) * 2002-02-12 2005-07-21 Sumitomo Pharmaceuticals Co., Ltd. Novel external agent
ATE399165T1 (de) * 2003-09-12 2008-07-15 Rigel Pharmaceuticals Inc Chinolinverbindungen und deren verwendungen
WO2006004865A1 (en) * 2004-06-29 2006-01-12 Rigel Pharmaceuticals, Inc. 2-substituted quinoline compounds and their uses as inhibitors of the ige receptor signaling cascade
US20060024376A1 (en) * 2004-07-30 2006-02-02 The University Of Chicago Methods and compositions for reducing toxicity associated with leflunomide treatment
JOP20190207A1 (ar) 2017-03-14 2019-09-10 Actelion Pharmaceuticals Ltd تركيبة صيدلانية تشتمل على بونيسيمود

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK54063C (da) * 1935-02-22 1937-12-27 Hoffmann La Roche Fremgangsmaade til Fremstilling af dialkylsubstituerede Amider af Isoksazolkarbonsyrer.
DE634286C (de) * 1935-02-23 1936-08-26 Hoffmann La Roche & Co Akt Ges Verfahren zur Herstellung dialkylsubstituierter Amide von Isoxazolcarbonsaeuren
US2126329A (en) * 1936-03-20 1938-08-09 Hoffmann La Roche Amide derivatives of isoxazole carboxylic acids
DE673111C (de) * 1938-01-18 1939-03-16 Hoffmann La Roche & Co Akt Ges Verfahren zur Darstellung amidartiger Abkoemmlinge von Homologen der Isoxazolcarbonsaeuren
US2288863A (en) * 1940-02-27 1942-07-07 Hoffmann La Roche Process for the manufacture of substituted amides of 3,5-dimethylisoxazole-4-carboxylic acid
DK58903C (da) * 1940-02-27 1941-08-04 Hoffmann La Roche Fremgangsmaade til Fremstilling af substituerede Amider af 3,5-Dimetyl-isoksazol-karbonsyre-(4).

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991017748A1 (de) * 1990-05-18 1991-11-28 Hoechst Aktiengesellschaft Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung

Also Published As

Publication number Publication date
JPS527960A (en) 1977-01-21
ES448386A1 (es) 1978-04-16
IE43136L (en) 1976-12-05
DK151013C (da) 1988-03-07
CH603608A5 (nl) 1978-08-31
GB1547452A (en) 1979-06-20
CA1076584A (en) 1980-04-29
BE842689A (fr) 1976-12-08
AT349007B (de) 1979-03-12
ATA413776A (de) 1978-08-15
US4087535A (en) 1978-05-02
JPS5938230B2 (ja) 1984-09-14
LU75077A1 (nl) 1977-03-09
IT1063592B (it) 1985-02-11
NL178596C (nl) 1986-04-16
DK248376A (da) 1976-12-06
MX3144E (es) 1980-05-09
DK151013B (da) 1987-10-12
FR2313052B1 (nl) 1979-09-28
FR2313052A1 (fr) 1976-12-31
IE43136B1 (en) 1980-12-31

Similar Documents

Publication Publication Date Title
NL7605841A (nl) Isoxazoolderivaten, hun bereiding en geneesmid- delen met deze verbindingen.
NL7409597A (nl) Nieuwe orale geneesmiddelen en werkwijze voor hun bereiding.
NL7510342A (nl) Gesubstitueerde purineverbindingen en farmaceu- tische toepassing daarvan.
NL7612286A (nl) Piperidinederivaten en werkwijze voor hun be- reiding.
DK90376A (da) Medicinpakning
NL7713151A (nl) Isoxazoolderivaten, hun bereiding en geneesmid- delen met deze stoffen.
NL7505240A (nl) Farmaceutisch preparaat.
DK173676A (da) Stofbehandlingsprodukt
IL49171A0 (en) New indolylalkylpiperidine derivatives,their manufacture and pharmaceutical preparations containing them
NL7413536A (nl) Basisch gesubstitueerde 1,4-dihydro-2h-iso- chinolinederivaten en hun bereiding.
NL7608206A (nl) Thiazolidinederivaten en werkwijze voor hun bereiding.
NL7803896A (nl) Nieuwe pyrrolochinoxalineverbindingen, werkwijze voor hun bereiding en geneesmiddelen.
NL7811376A (nl) Nieuwe imidazo-benzoxaninen en hun zouten, werkwijze voor hun bereiding en farmaceutische samenstellingen.
NL7804887A (nl) Bisamidine-verbindingen, hun bereiding, en farmaceuti- sche mengsels die hen bevatten.
NL7604911A (nl) Anthrachinon-bis-amidinen en hun bereiding.
NL7510259A (nl) Uridinederivaat alsmede farmaceutisch preparaat.
NL7504171A (nl) Tetracyclinederivaten en hun bereiding.
NL7415993A (nl) (1-alkyl-5-nitro-imidazolyl-2-alkyl)-hetero- aryl-verbindingen en hun bereiding.
NL7713148A (nl) Isoxazoolderivaten, hun bereiding en deze ver- bindingen bevattende geneesmiddelen.
NL7707713A (nl) Werkwijze ter bereiding van nieuwe amino-alko- xybenzofuranverbindingen, en hun toepassing in geneesmiddelen.
NL7506362A (nl) Gentamicinederivaten, alsmede hun bereidingswijze en geneeskundige toepassingen.
NL7611159A (nl) Thiazolidinederivaten en werkwijze voor hun bereiding.
BE838507A (fr) Comprimes pharmaceutiques
NL7603307A (nl) Nieuwe heterocyclische verbindingen, de bereiding ervan en preparaten die deze verbindingen bevat- ten.
NL7513693A (nl) Diaryloxy-imidazolyl-o,n-acetalen, werkwijze ter bereiding alsmede de toepassing ervan als genees- middelen.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 960531